Clinical Trial Update: A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing denosumab to zoledronic acid for treating bone metastases in breast cancer; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Breast Cancer

Drugs mentioned

• Denosumab (denosumab)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Amgen | Conditions: Bone Metastases | Phase 3 | Status: COMPLETED | Results posted: 2014-03-10